[Indications for and hazards of anticoagulant therapy].
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D003374:Coumarins / Q000627:therapeutic use; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology; D005342:Fibrinolysis; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010630:Phenindione / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy; D013997:Time Factors; D014652:Vascular Diseases / Q000188:drug therapy*; D014688:Venoms / Q000627:therapeutic use
D000925:Anticoagulants; D003374:Coumarins; D014688:Venoms; D010630:Phenindione; D006493:Heparin
Indikationen und Gefahren der Antikoagulantientherapie.